cinacalcet has been researched along with Heart Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chertow, GM; Edenberg, HJ; Foroud, TM; Liu, S; Moe, SM; Robinson-Cohen, C; Schwantes-An, TH; Stedman, M; Vatta, M; Wetherill, L; Zheng, N | 1 |
| Johnson, DW; Mavridis, D; Palmer, SC; Ruospo, M; Strippoli, GFM; Tonelli, M | 1 |
| Chertow, GM; Decker, BS; Edenberg, HJ; Foroud, TM; Liu, S; Moe, SM; Schwantes-An, TH; Stedman, M; Vatta, M; Wetherill, L | 1 |
| Abdalla, S; Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC | 1 |
| Abdalla, S; Chertow, GM; Montez-Rath, ME; Parfrey, PS | 1 |
| Chertow, GM; Kim, SM; Leonard, MB; Long, J; Montez-Rath, ME; Norton, JA | 1 |
| Arampatzis, S; Bachtler, M; Block, GA; Chertow, GM; Floege, J; Jahnen-Dechent, W; Ma, X; Parfrey, P; Pasch, A; Smith, ER | 1 |
| Colin Forfar, J; Tilling, L | 1 |
1 review(s) available for cinacalcet and Heart Failure
| Article | Year |
|---|---|
Comparative Effectiveness of Calcimimetic Agents for Secondary Hyperparathyroidism in Adults: A Systematic Review and Network Meta-analysis.
Topics: Adult; Calcimimetic Agents; Calcium; Cardiovascular Diseases; Cinacalcet; Comorbidity; Female; Fractures, Bone; Heart Failure; Humans; Hyperparathyroidism, Secondary; Male; Mortality; Naphthalenes; Nausea; Parathyroid Hormone; Peptides; Pyrrolidines; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vomiting | 2020 |
2 trial(s) available for cinacalcet and Heart Failure
| Article | Year |
|---|---|
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
Topics: Atherosclerosis; Calcimimetic Agents; Cinacalcet; Death, Sudden, Cardiac; Double-Blind Method; Female; Heart Failure; Humans; Hyperparathyroidism, Secondary; Intention to Treat Analysis; Kidney Failure, Chronic; Male; Naphthalenes; Renal Dialysis; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Calcinosis; Cardiovascular Diseases; Cause of Death; Cinacalcet; Female; Heart Failure; Hematologic Tests; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Survival Rate | 2017 |
5 other study(ies) available for cinacalcet and Heart Failure
| Article | Year |
|---|---|
APOL1 G3 Variant Is Associated with Cardiovascular Mortality and Sudden Cardiac Death in Patients Receiving Maintenance Hemodialysis of European Ancestry.
Topics: Apolipoprotein L1; Cinacalcet; Death, Sudden, Cardiac; Heart Failure; Humans; Renal Dialysis | 2022 |
Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
Topics: Adult; Aged; Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Death, Sudden, Cardiac; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Genetic Predisposition to Disease; Glucuronidase; Heart Failure; Humans; Hyperparathyroidism, Secondary; Kaplan-Meier Estimate; Klotho Proteins; Male; Middle Aged; Multicenter Studies as Topic; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Receptor, Fibroblast Growth Factor, Type 4; Renal Dialysis | 2019 |
The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.
Topics: Aged; Angina, Unstable; Calcimimetic Agents; Cause of Death; Cinacalcet; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cinacalcet; Female; Heart Failure; Hospital Mortality; Humans; Hyperparathyroidism, Secondary; Incidence; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Length of Stay; Male; Middle Aged; Parathyroidectomy; Peripheral Vascular Diseases; Treatment Outcome; United States; Young Adult | 2016 |
Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy.
Topics: Calcium; Cardiomyopathies; Cardiotonic Agents; Cinacalcet; Drug Administration Schedule; Heart Failure; Hemofiltration; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Probability; Shock, Cardiogenic | 2007 |